-
Product Insights
NewLikelihood of Approval Analysis for Food Allergy
Overview How likely is it that the drugs in Food Allergy will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Food Allergy Overview Food allergies are immune system reactions to certain proteins...
-
Product Insights
NewLikelihood of Approval Analysis for Pituitary Gland Disorders
Overview How likely is it that the drugs in Pituitary Gland Disorders will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Pituitary Gland Disorders Overview Pituitary gland disorders involve dysregulation of the...
-
Product Insights
NewAccenture Plc Partner Ecosystem Profile
GlobalData's new report titled "Accenture Plc Partner Ecosystem Profile " serves as a crucial resource for analyzing the partner landscape of Accenture Plc. It identifies the company's partners across various countries and regions, and tracks over 70 data fields including IT solution areas of interest, business fundamental data (such as revenue and employee bands), partner engagement signing country, focused verticals, and more.It is based on data and information gathered from a range of sources including company websites, press releases, CXO...
-
Product Insights
NewCisco Systems Inc. Partner Ecosystem Profile
GlobalData's new report titled "Cisco Systems Inc. Partner Ecosystem Profile " serves as a crucial resource for analyzing the partner landscape of Cisco Systems Inc.. It identifies the company's partners across various countries and regions, and tracks over 70 data fields including IT solution areas of interest, business fundamental data (such as revenue and employee bands), partner engagement signing country, focused verticals, key executive details, and more.It is based on data and information gathered from a range of sources including...
-
Product Insights
NewLikelihood of Approval Analysis for Leukocyte Disorders (White Blood Cell Disorders)
Overview How likely is it that the drugs in Leukocyte Disorders (White Blood Cell Disorders) will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Leukocyte Disorders (White Blood Cell Disorders) Overview Leukocyte...
-
Product Insights
NewLikelihood of Approval Analysis for Hyperoxaluria
Overview How likely is it that the drugs in Hyperoxaluria will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Hyperoxaluria Overview Hyperoxaluria, a rare condition, manifests with recurrent kidney and bladder stones,...
-
Product Insights
NewLikelihood of Approval Analysis for Acute Ischemic Stroke
Overview How likely is it that the drugs in Acute Ischemic Stroke will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Acute Ischemic Stroke Overview An acute ischemic stroke occurs when a...
-
Product Insights
NewLikelihood of Approval Analysis for Major Depressive Disorder
Overview How likely is it that the drugs in Major Depressive Disorder will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Major Depressive Disorder Overview Major Depressive Disorder (MDD) is a common...
-
Product Insights
NewLikelihood of Approval Analysis for Metastatic Hepatocellular Carcinoma (HCC)
Overview How likely is it that the drugs in Metastatic Hepatocellular Carcinoma (HCC) will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Metastatic Hepatocellular Carcinoma (HCC) Overview Metastatic hepatocellular carcinoma (HCC) refers...
-
Product Insights
NewLikelihood of Approval Analysis for Metastatic Ovarian Cancer
Overview How likely is it that the drugs in Metastatic Ovarian Cancer will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Metastatic Ovarian Cancer Overview Metastatic ovarian cancer results from the spread...